1. Home
  2. DLPN vs RLYB Comparison

DLPN vs RLYB Comparison

Compare DLPN & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.65

Market Cap

21.8M

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$0.64

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
RLYB
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.8M
24.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DLPN
RLYB
Price
$1.65
$0.64
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
34.5K
202.1K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,371,115.00
$674,000.00
Revenue This Year
$9.05
N/A
Revenue Next Year
$15.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
12.71
52 Week Low
$0.75
$0.22
52 Week High
$1.88
$1.24

Technical Indicators

Market Signals
Indicator
DLPN
RLYB
Relative Strength Index (RSI) 48.38 54.42
Support Level $1.60 $0.59
Resistance Level $1.84 $0.68
Average True Range (ATR) 0.12 0.04
MACD -0.02 -0.00
Stochastic Oscillator 31.58 44.50

Price Performance

Historical Comparison
DLPN
RLYB

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: